Novartis to run COVID-19 trial of antimalaria drug touted by Trump By: MarketWatch April 20, 2020 at 05:49 AM EDT The antimalaria drug that President Donald Trump has repeatedly touted will be put to the test. Read More >> Related Stocks: Gilead Sciences Novartis Ag ADR